共 50 条
- [21] Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis REPLY NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01): : 91 - 91
- [22] General health status in patients with moderate to severe ulcerative colitis receiving ustekinumab: results from the Phase 3 UNIFI induction and maintenance studies JOURNAL OF CROHNS & COLITIS, 2019, 13 : S311 - S312
- [26] Efficacy and safety of ustekinumab for Ulcerative Colitis through 4 years in Asian patients: Final results from the sub-population of UNIFI long-term extension JOURNAL OF CROHNS & COLITIS, 2023, 17 : 566 - 568
- [27] Early Improvement After Intravenous Ustekinumab Induction in Patients With Ulcerative Colitis: Results From the UNIFI Induction Trial AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S404 - S404
- [30] Effect of Ustekinumab Maintenance Therapy on Stool Frequency and Rectal Bleeding Through 2 Years in the UNIFI Phase 3 Study in Ulcerative Colitis AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S398 - S398